The relationship between administered radiopharmaceutical activity in myocardial perfusion scintigraphy and imaging outcome

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 2, 2008, Pages 329-335

  Robinson, C N ^a   Van Aswegen, A ^a   Julious, S A ^b   Nunan, T O ^c   Thomson, W H ^d   Tindale, W B ^e   Tout, D A ^a   Underwood, S R ^a,f,g  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d SANDWELL AND WEST BIRMINGHAM HOSPITALS NHS TRUST   (United Kingdom)

^e SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Activity; Image quality; MPS; Outcome; Radiopharmaceutical

Indexed keywords

RADIOPHARMACEUTICAL AGENT; TETROFOSMIN TC 99M;

ADULT; ARTICLE; DRUG ACTIVITY; ELECTROCARDIOGRAM; FEMALE; HUMAN; IMAGING; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION SCINTIGRAPHY; OUTCOME ASSESSMENT; SCINTIGRAPHY;

AGED; CORONARY ARTERY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 38349127569     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0597-9     Document Type: Article

References (14)

1. Administration of Radioactive Substances Advisory Committee. Notes for guidance on the clinical administration of radiopharmaceuticals and use of sealed radioactive sources. March 2006.
2. IAEA Safety Series No 115, International Basic Safety Standards for Protection against Ionizing Radiation and for the Safety of Radiation Sources (1996), p. 283.
3. Anagnostopoulos CA, Harbinson MT, Kelion A, et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart 2003;89:1156-6.
4. Kapur A, Latus KA, Davies G, et al. A comparison of three radionuclide myocardial perfusion tracers in clinical practice: the ROBUST Study. Eur J Nucl Med 2002;29:1608-16.
5. Germano G, Kiat H, Kavanagh PB, et al. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 1995;36:2138-47.
6. Julious SA. Using confidence intervals around individual means to assess statistical significance between two means. Pharmaceut Statist 2004;3:217-22.
7. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74.
8. Squassante L, Robinson CN, Palmer RL. Simple graphical methods of displaying multiple clinical results. Pharmaceut Statist 2006;5:51-60.
9. Donner A. Sample size requirements for the comparison of two or more coefficients of inter-observer agreement. Stat Med 1998;17:1157-68.
10. Fisher RA. Statistical methods for research workers. 13th ed. New Jersey: Hafner Publishing Company Inc; 1958.
11. Rollo FD. Nuclear medicine physics, instrumentation, and agents. Saint Louis: CV Mosby; 1977, p. 395 (ISBN 0-8016-4181-0).
12. Cherry SR, Sorenson JA, Phelps ME. Physics in nuclear medicine (3rd ed). PA: Saunders 2003, p. 267 (ISBN 0-7216-8341-X).
13. Bavelaar-Croon CDL, Pauwels EKJ, van der Wall EE. Gated single-photon emission computed tomographic myocardial imaging: a new tool in clinical cardiology. Am Heart J 2001;141:383-90.
14. Notghi A, Williams N, Smith NK, Goyle S, Harding LK. Relationship between myocardial counts and patient weight: adjusting the injection activity in myocardial perfusion scans. Nucl Med Commun 2003;24:55-9.